MSI2 and non-small cell lung carcinoma: Furthermore, elevated MSI2 expression drives oncogenesis and facilitates distant dissemination across multiple malignancies, including leukemias [17,18], non-small cell lung cancer (NSCLC) [19] and breast cancer [20].